Understanding cardiogenic shock in patients admitted to intensive care
Pharmacological and Mechanical Support Approaches in the Management of Acute Heart Failure in the Regional Network Model for the Management of Cardiogenic Shock
IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06827314
This study looks at how common cardiogenic shock is in patients in intensive care and what happens to them based on their age, sex, and the cause of their condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna (other) |
| Locations | 1 site (Bologna, Bologna) |
| Trial ID | NCT06827314 on ClinicalTrials.gov |
What this trial studies
This observational study aims to describe the epidemiology of cardiogenic shock in the Emilia Romagna region, focusing on outcomes based on different causes, sex, and age. It will analyze the incidence of cardiogenic shock among cardiac intensive care unit admissions, in-hospital mortality rates, and length of hospital stays. The study will include both retrospective and prospective cohorts of patients diagnosed with cardiogenic shock, with data collected on their demographics, treatment strategies, and clinical outcomes. Patients will receive standard care as determined by their physicians, with no experimental interventions involved.
Who should consider this trial
Good fit: Ideal candidates include adult patients aged 18 and older who are admitted to a cardiac intensive care unit with suspected cardiogenic shock.
Not a fit: Patients who have experienced cardiogenic shock following cardiac surgery or those with significant polytrauma or neurological injuries may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the management and outcomes of cardiogenic shock, potentially improving patient care strategies.
How similar studies have performed: While this study is observational and focuses on epidemiology, similar studies have provided valuable data on cardiogenic shock management, suggesting that understanding this condition can lead to improved outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (≥18 years old) admitted to a participating CICU with suspected CS of stage from C to E according to SCAI (Society of cardiovascular intervention)classification of cardiogenic shock. * Signed informed consent. Exclusion Criteria: * CS following cardiac surgery (post-cardiotomy), ● Significant polytrauma or neurological injury.
Where this trial is running
Bologna, Bologna
- IRCCS Azienda Ospedaliero-Universitaria di Bologna — Bologna, Bologna, Italy (RECRUITING)
Study contacts
- Principal investigator: Luciano G Potena, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Luciano Potena, MD
- Email: scompenso.trapiantocuore@aosp.bo.it
- Phone: 0512143725
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cardiogenic Shock, Acute Coronary Event